Saadi Ryan H.

Insider Reports History

Reporting-owner location: Warren, NJ
Latest reporting-owner signature: /s/ Kirti Desai, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Saadi Ryan H.

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Tevogen Bio Holdings Inc.

Security class: Common Stock
Shares / value: 3,705,689
Estimated value: $20,974,570
Report date: 10 Jul 2026
Price: $5.66
Ownership: Direct

Form 4 holding Chief Executive Officer, Director, 10%+ Owner

Tevogen Bio Holdings Inc.

Security class: Common Stock
Shares / value: 3,878
Estimated value: $21,949
Report date: 10 Jul 2026
Price: $5.66
Ownership: By wife

Insider Reports Filed by Saadi Ryan H.

4 TVGN

Tevogen Bio Holdings Inc.

Report period: 10 Jul 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Jul 2026, 17:31
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TVGN

Tevogen Bio Holdings Inc.

Report period: 18 Dec 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 22 Dec 2025, 17:43
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TVGN

Tevogen Bio Holdings Inc.

Report period: 11 Dec 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 12 Dec 2025, 18:51
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TVGN

Tevogen Bio Holdings Inc.

Report period: 15 Aug 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 18 Aug 2025, 16:59
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TVGN

Tevogen Bio Holdings Inc.

Report period: 27 Jun 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 01 Jul 2025, 16:49
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TVGN

Tevogen Bio Holdings Inc.

Report period: 09 Jun 2025
Transactions: 1
Transaction value: -$1,768,993
Accepted by SEC: 09 Jun 2025, 19:13
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TVGN

Tevogen Bio Holdings Inc.

Report period: 05 Jun 2024
Transactions: 1
Transaction value: +$2,000
Accepted by SEC: 07 Jun 2024, 16:29
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

4 TVGN

Semper Paratus Acquisition Corp

Report period: 14 Feb 2024
Transactions: 3
Transaction value: $0
Accepted by SEC: 16 Feb 2024, 17:28
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

3 TVGN

Semper Paratus Acquisition Corp

Report period: 14 Feb 2024
Transactions: 0
Transaction value: $0
Accepted by SEC: 16 Feb 2024, 17:11
Role: Chief Executive Officer, Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .